Market Definition:
Preimplantation Genetic Testing (PGT) is a type of genetic testing that is done on embryos before implantation in the uterus. It is primarily used to screen for genetic abnormalities that may be present in the embryo. This testing is usually done in conjunction with in vitro fertilization (IVF) treatments and can help to identify chromosomal abnormalities, aneuploidies, and other genetic diseases.
PGT is done by taking a biopsy of a few cells from the embryo, which is typically done after the embryo has reached the 8-cell stage. These cells are then tested for genetic abnormalities using a variety of methods, such as polymerase chain reaction (PCR), fluorescent in situ hybridization (FISH), or comparative genomic hybridization (CGH). If the testing reveals an abnormality or disease, the embryo can then be discarded.
PGT is a highly effective method for screening out embryos with genetic abnormalities and can help to increase the chances of successful implantation and pregnancy. However, it is important to note that no test is 100% accurate and that some abnormalities may still be present in the embryo even after PGT has been done. Additionally, PGT is an expensive procedure and is not always covered by insurance.
To Know More: https://www.globalinsightservices.com/reports/preimplantation-genetic-testing-market/
Market Outlook:
The key trends in PGT market are:
The first trend is the use of next-generation sequencing (NGS). NGS is a powerful tool that allows for the sequencing of a large number of genes in a single test. This allows for the identification of more genetic disorders with a single test and reduces the time and cost associated with traditional PGT. Additionally, NGS can detect genetic abnormalities that cannot be identified with traditional PGT.
The second trend is the use of comprehensive chromosome screening (CCS). CCS is a more advanced form of PGT that can detect chromosomal abnormalities in addition to genetic disorders. CCS is a valuable tool for couples who are at risk of having a child with a chromosomal disorder, such as Down Syndrome. CCS can also be used to detect chromosomal abnormalities that are not associated with any particular disorder.
Key Drivers
Preimplantation Genetic Testing (PGT) is a type of genetic testing used to diagnose certain genetic disorders in embryos prior to implantation. It is used to select embryos for in vitro fertilization (IVF) that are free from specific inherited diseases and to increase the chances of a successful pregnancy. The key drivers of the Preimplantation Genetic Testing market are:
1. Increasing Prevalence of Inherited Diseases: The prevalence of inherited diseases is increasing due to various factors such as inbreeding, poor nutrition, and environmental factors. This is driving the demand for preimplantation genetic testing as it can help identify and prevent the transmission of genetic disorders from parents to their offspring.
2. Technological Advancements: The development of PGT techniques such as next-generation sequencing (NGS), single-nucleotide polymorphism (SNP) array technology, and preimplantation genetic testing for aneuploidy (PGT-A) has led to a significant reduction in the cost of genetic testing and an increased accuracy of results. This has resulted in an increased demand for preimplantation genetic testing.
Restraints & Challenges
Preimplantation genetic testing (PGT) is a type of genetic testing that is done prior to the implantation of an embryo in the uterus. This testing is used to detect genetic diseases and chromosomal abnormalities in the embryo prior to implantation.
While PGT has been available for over two decades, it has only recently become more widely used and accepted. This is because of the advances in technology, such as the introduction of next-generation sequencing, which have allowed for more accurate and efficient testing.
Despite the advantages of PGT, there are several key restraints and challenges that must be addressed in order for it to become more widely accepted. The most significant of these are the potential ethical issues associated with the testing, the cost of the tests, and the potential for false positives or negatives.
Request Sample: https://www.globalinsightservices.com/request-sample/GIS26229
Research Objectives:
• Estimates and forecast the overall market size for the total market, across product, service type, type, end-user, and region
• Detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling
• Identify factors influencing market growth and challenges, opportunities, drivers and restraints
• Identify factors that could limit company participation in identified international markets to help properly calibrate market share expectations and growth rates
• Trace and evaluate key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities
• Thoroughly analyze smaller market segments strategically, focusing on their potential, individual patterns of growth, and impact on the overall market
• To thoroughly outline the competitive landscape within the market, including an assessment of business and corporate strategies, aimed at monitoring and dissecting competitive advancements.
• Identify the primary market participants, based on their business objectives, regional footprint, product offerings, and strategic initiatives
Request Customization: https://www.globalinsightservices.com/request-customization/GIS26229
Market Segments
The global Preimplantation Genetic Testing Market is segmented by type of testing, technology, end-user, and region. By type of testing, the market is divided intopgt-a (aneuploidy screening), pgt-m (monogenic disorders), pgt-sr (structural rearrangement). Based on technology, it is bifurcated into next-generation sequencing (ngs), polymerase chain reaction (pcr), fluorescence in situ hybridization (fish). On the basis of end-user, the market is classified into fertility clinics, hospitals and clinics, research institutes. Region-wise, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World.
Key Players
The global Preimplantation Genetic Testing Market report includes players like Illumina, Inc. (United States), Thermo Fisher Scientific, Inc. (United States), Agilent Technologies, Inc. (United States), PerkinElmer, Inc. (United States), CooperSurgical, Inc. (United States), Natera, Inc. (United States), Rubicon Genomics, Inc. (United States), F. Hoffmann-La Roche AG (Switzerland), Yikon Genomics Co., Ltd. (China), Yourgene Health (United Kingdom).
Request Discounted Pricing: https://www.globalinsightservices.com/request-special-pricing/GIS26229
Research Scope:
• Scope – Highlights, Trends, Insights. Attractiveness, Forecast
• Market Sizing – Product Type, End User, Offering Type, Technology, Region, Country, Others
• Market Dynamics – Market Segmentation, Demand and Supply, Bargaining Power of Buyers and Sellers, Drivers, Restraints, Opportunities, Threat Analysis, Impact Analysis, Porters 5 Forces, Ansoff Analysis, Supply Chain
• Business Framework – Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments
• Competitive Landscape – Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis
• Company Profiles – Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis
Buy your copy here: https://www.globalinsightservices.com/checkout/single_user/GIS26229
About Us:
With Global Insight Services, you receive:
• 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Infographic excel data pack, easy to analyze big data
• Robust and transparent research methodology
• Unmatched data quality and after sales service
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.